The resolution urges WHO member states to build national and subnational systems to ensure uninterrupted access to medical oxygen to healthcare facilities in both urban and rural areas.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check out the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
Regulators, pharmacists, and healthcare providers are alarmed by the trend.
Problems that have plagued the healthcare industry for years won't go away with the end of the COVID-19 public health emergency.
The drug has no therapeutic equivalents, meaning that some prostate cancer patients have been unable to secure their only treatment option.
All but 3 of these drugs are on the Resilient Drug Supply Project's (RDSP's) Critical Acute and COVID-19 Drug List.
Legislators have asked the FDA commissioner to answer questions by today on such issues as the country of origin for the manufacture and processing of each drug in shortage.
The European Union (EU) Commission plans to publish a draft of the largest overhaul of medical laws in 20 years.
From 2021 to 2022, new drug shortages rose by nearly 30%, with the average shortage lasting 1.5 years.
Injectable methotrexate, cisplatin, fluorouracil, and Pluvicto are in shortage, with no definitive end in sight.
There is no cheap alternative to liquid albuterol, which is used in nebulizers to treat children too young to use an inhaler.
Chinese export of active pharmaceutical ingredients has been complicated by pandemic-related supply-chain chaos and, more recently, the lifting of the country's zero-COVID policy.